Cargando…

Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas

OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for...

Descripción completa

Detalles Bibliográficos
Autores principales: Habert, Paul, Decoux, Antoine, Chermati, Lilia, Gibault, Laure, Thomas, Pascal, Varoquaux, Arthur, Le Pimpec-Barthes, Françoise, Arnoux, Armelle, Juquel, Loïc, Chaumoitre, Kathia, Garcia, Stéphane, Gaubert, Jean-Yves, Duron, Loïc, Fournier, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509085/
https://www.ncbi.nlm.nih.gov/pubmed/37726504
http://dx.doi.org/10.1186/s13244-023-01484-9
_version_ 1785107665515446272
author Habert, Paul
Decoux, Antoine
Chermati, Lilia
Gibault, Laure
Thomas, Pascal
Varoquaux, Arthur
Le Pimpec-Barthes, Françoise
Arnoux, Armelle
Juquel, Loïc
Chaumoitre, Kathia
Garcia, Stéphane
Gaubert, Jean-Yves
Duron, Loïc
Fournier, Laure
author_facet Habert, Paul
Decoux, Antoine
Chermati, Lilia
Gibault, Laure
Thomas, Pascal
Varoquaux, Arthur
Le Pimpec-Barthes, Françoise
Arnoux, Armelle
Juquel, Loïc
Chaumoitre, Kathia
Garcia, Stéphane
Gaubert, Jean-Yves
Duron, Loïc
Fournier, Laure
author_sort Habert, Paul
collection PubMed
description OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for hamartomas or carcinoids with contrast-enhanced chest-CT were retrospectively reviewed. Semantic criteria were recorded and radiomics features were extracted from 3D segmentations using Pyradiomics. Reproducible and non-redundant radiomics features were used to training a random forest algorithm with cross-validation. A validation-set from another institution was used to evaluate of the radiomics signature, the 3D ‘median’ attenuation feature (3D-median) alone and the mean value from 2D-ROIs. RESULTS: Seventy-three patients (median 58 years [43‒70]) were analyzed (16 hamartomas; 57 carcinoids). The radiomics signature predicted hamartomas vs carcinoids on the external dataset (22 hamartomas; 32 carcinoids) with an AUC = 0.76. The 3D-median was the most important in the model. Density thresholds < 10 HU to predict hamartoma and > 60 HU to predict carcinoids were chosen for their high specificity > 0.90. On the external dataset, sensitivity and specificity of the 3D-median and 2D-ROIs were, respectively, 0.23, 1.00 and 0.13, 1.00 < 10 HU; 0.63, 0.95 and 0.69, 0.91 > 60 HU. The 3D-median was more reproducible than 2D-ROIs (ICC = 0.97 95% CI [0.95‒0.99]; bias: 3 ± 7 HU limits of agreement (LoA) [− 10‒16] vs. ICC = 0.90 95% CI [0.85‒0.94]; bias: − 0.7 ± 21 HU LoA [− 4‒40], respectively). CONCLUSIONS: A radiomics signature can distinguish hamartomas from carcinoids with an AUC = 0.76. Median density < 10 HU and > 60 HU on 3D or 2D-ROIs may be useful in clinical practice to diagnose these tumors with confidence, but 3D is more reproducible. CRITICAL RELEVANCE STATEMENT: Radiomic features help to identify the most discriminating imaging signs using random forest. ‘Median’ attenuation value (Hounsfield units), extracted from 3D-segmentations on contrast-enhanced chest-CTs, could distinguish carcinoids from atypical hamartomas (AUC = 0.85), was reproducible (ICC = 0.97), and generalized to an external dataset. KEY POINTS: • 3D-‘Median’ was the best feature to differentiate carcinoids from atypical hamartomas (AUC = 0.85). • 3D-‘Median’ feature is reproducible (ICC = 0.97) and was generalized to an external dataset. • Radiomics signature from 3D-segmentations differentiated carcinoids from atypical hamartomas with an AUC = 0.76. • 2D-ROI value reached similar performance to 3D-‘median’ but was less reproducible (ICC = 0.90). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01484-9.
format Online
Article
Text
id pubmed-10509085
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-105090852023-09-21 Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas Habert, Paul Decoux, Antoine Chermati, Lilia Gibault, Laure Thomas, Pascal Varoquaux, Arthur Le Pimpec-Barthes, Françoise Arnoux, Armelle Juquel, Loïc Chaumoitre, Kathia Garcia, Stéphane Gaubert, Jean-Yves Duron, Loïc Fournier, Laure Insights Imaging Original Article OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for hamartomas or carcinoids with contrast-enhanced chest-CT were retrospectively reviewed. Semantic criteria were recorded and radiomics features were extracted from 3D segmentations using Pyradiomics. Reproducible and non-redundant radiomics features were used to training a random forest algorithm with cross-validation. A validation-set from another institution was used to evaluate of the radiomics signature, the 3D ‘median’ attenuation feature (3D-median) alone and the mean value from 2D-ROIs. RESULTS: Seventy-three patients (median 58 years [43‒70]) were analyzed (16 hamartomas; 57 carcinoids). The radiomics signature predicted hamartomas vs carcinoids on the external dataset (22 hamartomas; 32 carcinoids) with an AUC = 0.76. The 3D-median was the most important in the model. Density thresholds < 10 HU to predict hamartoma and > 60 HU to predict carcinoids were chosen for their high specificity > 0.90. On the external dataset, sensitivity and specificity of the 3D-median and 2D-ROIs were, respectively, 0.23, 1.00 and 0.13, 1.00 < 10 HU; 0.63, 0.95 and 0.69, 0.91 > 60 HU. The 3D-median was more reproducible than 2D-ROIs (ICC = 0.97 95% CI [0.95‒0.99]; bias: 3 ± 7 HU limits of agreement (LoA) [− 10‒16] vs. ICC = 0.90 95% CI [0.85‒0.94]; bias: − 0.7 ± 21 HU LoA [− 4‒40], respectively). CONCLUSIONS: A radiomics signature can distinguish hamartomas from carcinoids with an AUC = 0.76. Median density < 10 HU and > 60 HU on 3D or 2D-ROIs may be useful in clinical practice to diagnose these tumors with confidence, but 3D is more reproducible. CRITICAL RELEVANCE STATEMENT: Radiomic features help to identify the most discriminating imaging signs using random forest. ‘Median’ attenuation value (Hounsfield units), extracted from 3D-segmentations on contrast-enhanced chest-CTs, could distinguish carcinoids from atypical hamartomas (AUC = 0.85), was reproducible (ICC = 0.97), and generalized to an external dataset. KEY POINTS: • 3D-‘Median’ was the best feature to differentiate carcinoids from atypical hamartomas (AUC = 0.85). • 3D-‘Median’ feature is reproducible (ICC = 0.97) and was generalized to an external dataset. • Radiomics signature from 3D-segmentations differentiated carcinoids from atypical hamartomas with an AUC = 0.76. • 2D-ROI value reached similar performance to 3D-‘median’ but was less reproducible (ICC = 0.90). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01484-9. Springer Vienna 2023-09-19 /pmc/articles/PMC10509085/ /pubmed/37726504 http://dx.doi.org/10.1186/s13244-023-01484-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Habert, Paul
Decoux, Antoine
Chermati, Lilia
Gibault, Laure
Thomas, Pascal
Varoquaux, Arthur
Le Pimpec-Barthes, Françoise
Arnoux, Armelle
Juquel, Loïc
Chaumoitre, Kathia
Garcia, Stéphane
Gaubert, Jean-Yves
Duron, Loïc
Fournier, Laure
Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title_full Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title_fullStr Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title_full_unstemmed Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title_short Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
title_sort best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509085/
https://www.ncbi.nlm.nih.gov/pubmed/37726504
http://dx.doi.org/10.1186/s13244-023-01484-9
work_keys_str_mv AT habertpaul bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT decouxantoine bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT chermatililia bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT gibaultlaure bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT thomaspascal bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT varoquauxarthur bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT lepimpecbarthesfrancoise bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT arnouxarmelle bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT juquelloic bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT chaumoitrekathia bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT garciastephane bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT gaubertjeanyves bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT duronloic bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas
AT fournierlaure bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas